ACXP icon

Acurx Pharmaceuticals
ACXP

Overview Fund Activity

25 hedge funds and large institutions have $2.71M invested in Acurx Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 4 closing their positions.

Holders
25
Holders Change
-1
Holders Change %
-3.85%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
9
Reduced
3
Closed
4
Calls
$78K
Puts
$56K
Net Calls
+$22K
Net Calls Change
+$9K

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$104K
2
Geode Capital Management
2
Geode Capital Management
Massachusetts
$293K
3
LPL Financial
3
LPL Financial
California
$121K
4
Northern Trust
4
Northern Trust
Illinois
$61.4K
5
BlackRock
5
BlackRock
New York
$61.9K

Top Sellers

1
Osaic Holdings
1
Osaic Holdings
Arizona
$34.2K
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$0
3
XT
3
XTX Topco
Cayman Islands
$0
4
Two Sigma Investments
4
Two Sigma Investments
New York
$0
5
Group One Trading
5
Group One Trading
Illinois
$11.8K
Name Market Value Shares Shares
Change 		Shares
Change %
XT
26
XTX Topco
Cayman Islands
– – -13,041 Closed
Two Sigma Investments
27
Two Sigma Investments
New York
– – -12,986 Closed
Wells Fargo
28
Wells Fargo
California
– – -87 Closed
CFGS
29
Concourse Financial Group Securities
Alabama
– – – –
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
$0 132 +95 +257%
1
2